Karen Potter
Karen G Potter Ph.D. | Morrison Foerster Karen Potter is a partner in Morrison Foerster’s Life Sciences Patent group. Her practice focuses on patent preparation, prosecution, and strategic counseling for start‑up, emerging, and established life sciences and biotechnology companies. She advises clients in the development and management of comprehensive patent portfolios that match their scientific and business objectives. Karen also helps identify and evaluate patentability, ensure freedom to operate, and perform due diligence review of patent portfolios for clients, including investor-side and target-side due diligence. Building on her technical expertise in cellular and molecular biology and immunology, Karen has experience managing and developing patent portfolios in the areas of cell and gene therapies, including T-cell therapies, Natural Killer cell-based therapies, stem cell therapies and gene-based therapies; protein therapeutics such as immunotherapies, including antibody and protein-based therapies; virus therapies; companion diagnostics; and diagnostic assays and bioassays. · Morrison Foerster
About
Karen Potter is a partner in Morrison Foerster's Life Sciences Patent group, focusing on patent preparation, prosecution, and strategic counseling for life sciences and biotechnology companies. She also advises on patent portfolio management, patentability analysis, freedom to operate, and due diligence, with notable expertise in cell and gene therapies, protein therapeutics, immunotherapies, virus therapies, companion diagnostics, and diagnostic assays.